Joel A Sincavage

Array ( [id] => 1575696 [patent_doc_number] => 06469140 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Molecules of the card-related protein family and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/207359 [patent_app_country] => US [patent_app_date] => 1998-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 29 [patent_no_of_words] => 57968 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469140.pdf [firstpage_image] =>[orig_patent_app_number] => 09207359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4262883 [patent_doc_number] => 06258935 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'LSIRF polypeptides' [patent_app_type] => 1 [patent_app_number] => 9/195940 [patent_app_country] => US [patent_app_date] => 1998-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 35 [patent_no_of_words] => 16667 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258935.pdf [firstpage_image] =>[orig_patent_app_number] => 195940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1414813 [patent_doc_number] => 06528700 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Targeted manipulation of genes in plants' [patent_app_type] => B1 [patent_app_number] => 09/193612 [patent_app_country] => US [patent_app_date] => 1998-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 26 [patent_no_of_words] => 12435 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528700.pdf [firstpage_image] =>[orig_patent_app_number] => 09193612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177061 [patent_doc_number] => 06037172 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Retroviral vector, a replication system for said vector and avian or mammalian cells transfected with said vector' [patent_app_type] => 1 [patent_app_number] => 9/169078 [patent_app_country] => US [patent_app_date] => 1998-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 7760 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037172.pdf [firstpage_image] =>[orig_patent_app_number] => 169078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4158329 [patent_doc_number] => 06107478 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Retroviral vector, a replication system for said vector and avian or mammalian cells transfected with said vector' [patent_app_type] => 1 [patent_app_number] => 9/169248 [patent_app_country] => US [patent_app_date] => 1998-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 7775 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107478.pdf [firstpage_image] =>[orig_patent_app_number] => 169248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 785146 [patent_doc_number] => 06989270 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-24 [patent_title] => 'Using polyamide nucleic acid oligomers to engender a biological response' [patent_app_type] => utility [patent_app_number] => 09/168714 [patent_app_country] => US [patent_app_date] => 1998-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 26649 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/989/06989270.pdf [firstpage_image] =>[orig_patent_app_number] => 09168714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4204220 [patent_doc_number] => 06077709 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Antisense modulation of Survivin expression' [patent_app_type] => 1 [patent_app_number] => 9/163162 [patent_app_country] => US [patent_app_date] => 1998-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18288 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077709.pdf [firstpage_image] =>[orig_patent_app_number] => 163162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4180614 [patent_doc_number] => 06020198 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Antisense modulation of RIP-1 expression' [patent_app_type] => 1 [patent_app_number] => 9/161443 [patent_app_country] => US [patent_app_date] => 1998-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19662 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020198.pdf [firstpage_image] =>[orig_patent_app_number] => 161443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4002296 [patent_doc_number] => 06004814 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Antisense modulation of CD71 expression' [patent_app_type] => 1 [patent_app_number] => 9/161244 [patent_app_country] => US [patent_app_date] => 1998-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22639 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004814.pdf [firstpage_image] =>[orig_patent_app_number] => 161244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4217156 [patent_doc_number] => 06087343 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Antisense oligonucleotides targeted to .beta.-1 adrenoceptor and methods of use' [patent_app_type] => 1 [patent_app_number] => 9/152717 [patent_app_country] => US [patent_app_date] => 1998-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4350 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087343.pdf [firstpage_image] =>[orig_patent_app_number] => 152717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940092 [patent_doc_number] => 05989862 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Tab1 protein and DNA coding therefor' [patent_app_type] => 1 [patent_app_number] => 9/144178 [patent_app_country] => US [patent_app_date] => 1998-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 10266 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989862.pdf [firstpage_image] =>[orig_patent_app_number] => 144178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4301408 [patent_doc_number] => 06187559 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Phospholipase D gene' [patent_app_type] => 1 [patent_app_number] => 9/141206 [patent_app_country] => US [patent_app_date] => 1998-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14219 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187559.pdf [firstpage_image] =>[orig_patent_app_number] => 141206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4203558 [patent_doc_number] => 06077672 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Antisense modulation of TRADD expression' [patent_app_type] => 1 [patent_app_number] => 9/143212 [patent_app_country] => US [patent_app_date] => 1998-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20955 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077672.pdf [firstpage_image] =>[orig_patent_app_number] => 143212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1311893 [patent_doc_number] => 06610539 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Antisense oligonucleotide sequences as inhibitors of microorganisms' [patent_app_type] => B1 [patent_app_number] => 09/112580 [patent_app_country] => US [patent_app_date] => 1998-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 50 [patent_no_of_words] => 19755 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610539.pdf [firstpage_image] =>[orig_patent_app_number] => 09112580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1435978 [patent_doc_number] => 06355621 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Antigenomic oligodeoxynucleotides for treatment of infection by negative-stranded nonsegmented RNA viruses' [patent_app_type] => B1 [patent_app_number] => 09/105836 [patent_app_country] => US [patent_app_date] => 1998-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4666 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355621.pdf [firstpage_image] =>[orig_patent_app_number] => 09105836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409606 [patent_doc_number] => 06265389 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Microencapsulation and sustained release of oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/104549 [patent_app_country] => US [patent_app_date] => 1998-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 8226 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265389.pdf [firstpage_image] =>[orig_patent_app_number] => 104549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1223359 [patent_doc_number] => 06699654 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-02 [patent_title] => 'Antimicrobial agents diagnostic reagents, and vaccines based on unique apicomplexan parasite components' [patent_app_type] => B1 [patent_app_number] => 09/103331 [patent_app_country] => US [patent_app_date] => 1998-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 20 [patent_no_of_words] => 47589 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699654.pdf [firstpage_image] =>[orig_patent_app_number] => 09103331 [rel_patent_id] =>[rel_patent_doc_number] =>)